IL4 and depressive symptom measurement: We did not find significant differences in CSF levels of the co-primary outcome cytokines, IL-6 and IL-8, whereas IL-4 levels were 40%, MCP-1 levels were 25% and MIP-1β levels were 16% higher among patients with depression compared to controls.